NewGenIvf Group Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of July 2025 for NewGenIvf Group Limited, a foreign private issuer headquartered in Bangkok, Thailand. The report details a corporate action regarding the company's capital structure rather than operational financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a reverse stock split and does not contain financial performance data.
Material Changes
- Reverse Stock Split: The Company announced a one-for-five reverse stock split of its Class A Ordinary Shares.
- Effective Date: The split is effective at 12:01 a.m. (ET) on August 4, 2025.
- Share Count Reduction: Outstanding shares will decrease from 9,142,869 to approximately 1,828,574.
- Trading Details: Shares will continue to trade on the Nasdaq Capital Market under the symbol "NIVF" but with a new CUSIP number: G0544E303.
- Adjustments: All outstanding options, warrants, and convertible securities will be adjusted by dividing the exercisable share count by five.
- Fractional Shares: No fractional shares will be issued; shareholders entitled to fractions will receive one full post-split share.
Guidance, Outlook, and Risks
The filing does not provide management commentary on future guidance, outlook, risks, or contingencies. The primary purpose of this filing is to disclose the mechanics and timing of the reverse stock split.
Investor Verification Checklist
- Verify the new CUSIP number (G0544E303) for trading purposes starting August 4, 2025.
- Confirm the adjusted number of shares held in brokerage accounts post-split.
- Review the terms of any outstanding options or warrants to ensure they have been adjusted by the one-for-five ratio.
- Monitor the stock price on the Nasdaq Capital Market to ensure it reflects the split-adjusted basis.